Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis

Conclusion: BST-2 contributes to the emergence of neoplasia and malignant progression of breast cancer. Thus, BST-2 may (1) serve as a biomarker for aggressive breast cancers, and (2) be a novel target for breast cancer therapeutics.

http://breast-cancer-research.com/content/16/6/493

Source: Breast Cancer Research - December 13, 2014 Category: Cancer & Oncology Authors: Wadie Mahauad-FernandezKris DeMaliAlicia OlivierChioma Okeoma Source Type: research